Phase 1/Phase 2

Who we are

  • April 5, 2022
    Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
  • April 5, 2022
    The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
  • April 5, 2022
    Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
  • April 5, 2022
    Adoptive Cell Therapy Across Cancer Diagnoses
  • April 5, 2022
    Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies